-
Most Recent
Search Results
240 results for bmti
5 Medical Devices Stocks to Sell Now
The ratings of five Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
BMTX Stock Earnings: BM Technologies Misses EPS, Misses Revenue for Q4 2023
BMTX stock results show that BM Technologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
BMTX Stock Earnings: BM Technologies Beats EPS, Beats Revenue for Q1 2024
BMTX stock results show that BM Technologies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
RMTI Stock Earnings: Rockwell Medical Beats EPS, Beats Revenue for Q1 2024
RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
RMTI Stock Earnings: Rockwell Medical Beats EPS, Misses Revenue for Q4 2023
RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
3 Undervalued Stock Gems Selling for 50 Cents on the Dollar
Undervalued stock gems are abundant if you know where to look for them. Consider these three companies before someone else does.
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
SMTI stock results show that Sanara MedTech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Visa Inc (V) and Fiserv Inc (FISV)
Bristol-Myers (BMY) have rallied from a deeply oversold chart reading, while Visa’s (V) rally looks tempting and Fiserv (FISV) shares are sitting in a technical…
3 Pharmaceuticals to Profit on Obamacare
More people enrolling in health insurance, that likely means more prescriptions and ultimately more profits for pharmaceuticals.
3 Defensive Stocks to Buy During the Market Dip
Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside.
Why Twitter Inc (TWTR), Bristol-Myers Squibb Co (BMY) and Twilio Inc (TWLO) Are 3 of Today’s Worst Stocks
Twitter (TWTR), Bristol-Myers Squibb (BMY) and Twilio (TWLO) each uses more than their fair share of red ink on Monday.
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B”…
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…
Why Juniper Networks, Inc. (JNPR), Supervalu Inc. (SVU) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks
Juniper Networks (JNPR), Bristol-Myers Squibb (BMY) and Supervalu (SVU) lost their uphill battles they were forced to fight on Wednesday.
6 – 10 of 240 results
